Pain News and Research

Latest Pain News and Research

New science of happiness doing a profound disservice

The new sciences of happiness are generating lots of advice on how to keep smiling. The results are even being explored by policy wonks. So why does so much of it - work less, say thanks, keep fit - sound so trite? If it were that easy, wouldn't we all be happy by now? The reason is that a central and tricky question is being glossed over: just what is happiness? Moreover, how you try to promote happiness depends entirely on what you take happiness to be - and there's a wealth of choice in that.

13 Nov 2009

Southeast Pain Care supports American Pain Foundation

Southeast Pain Care, a division of Southeast Anesthesiology Consultants, is sponsoring the Dec. 3 performance of "Grease" at Ovens Auditorium and giving $10 for every ticket sold to the American Pain Foundation.

13 Nov 2009

Orthopedic surgeon specializes in cutting-edge shoulder procedures from a 45-minute technique

Orthopedic surgeon, Dr. Corey G. Solman specializes in cutting-edge shoulder procedures including everything from a 45-minute technique called shoulder resurfacing to a reversed shoulder replacement that relieves pain, restores shoulder function and improves range of motion.

13 Nov 2009

Findings on the use of Traumeel S in children with mucositis undergoing SCT presented

New research findings presented today at the Society for Integrative Oncology's (SIO) Sixth International Conference in New York show promise in assessing the efficacy and safety of complementary and alternative medicine (CAM) using traditional research methods.

13 Nov 2009

Root canal treatment: Pennsylvania Dental Association answers patients' questions

You're visiting the dentist for what you think is a routine checkup and cleaning when he or she says you need a root canal. Though it's a term you've probably heard before, now that you're the one in the chair, you may have several questions and feel apprehensive about your upcoming procedure.

13 Nov 2009

Laser expert develops new technique for hair removal in ethnic skin types

Dr. Jay Kulkin, MD, internationally recognized laser expert and Fellow of the American Society for Laser Medicine and Surgery (highest designation), has successfully developed a laser technique making laser hair removal burns in ethnic skin types a thing of the past.

13 Nov 2009

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

The U.S. Food and Drug Administration has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

13 Nov 2009

CRPS patients fare better with aggressive physiotherapy treatment, says new study

The saying "more pain, more gain" may be true for those already in terrible pain due to a chronic and debilitating condition, contrary to received wisdom. For those with Type I Complex Regional Pain Syndrome (CRPS), working through the pain of an aggressive physiotherapy program often leads to far better results than a more cautious pain-free approach.

13 Nov 2009

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

13 Nov 2009

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

Abbott announced today a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in biologics. PG110 is a novel biologic in Phase I clinical trial development that targets NGF for the treatment of chronic pain.

13 Nov 2009

Abbott to acquire the global rights to PanGenetics' new therapeutic for treatment of chronic pain

PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.

13 Nov 2009

Positive results from Lexicon Pharmaceuticals' LX1031 Phase 2 study for IBS

Lexicon Pharmaceuticals, Inc. announced today that the company's investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated positive results in clinically important parameters for the treatment of non-constipating irritable bowel syndrome (IBS).

13 Nov 2009

Mouth: A diagnostic indicator for general health

The mouth or oral cavity area is an excellent indicator of the whole body's health, says Mao, who is the chair of the new Department of Oncology and Diagnostic Sciences at the School.

13 Nov 2009

Bioniche Pharma acquires injectable drugs from Xanodyne Pharmaceuticals

Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the acquisition of Duraclon® (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals, Inc.

13 Nov 2009

Artificially increasing selenium status above the level required is unwarranted, study calls for further research

A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost 10%.

12 Nov 2009

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers.

12 Nov 2009

Frequent heartburn is painful and impacts the quality of life: Study

While most adults have likely experienced the uncomfortable symptoms of heartburn at least once, for the 50 million American adults who suffer from frequent heartburn two or more days per week, the condition is not only painful, it can also impact their quality of life.

12 Nov 2009

A discreet option for pain relief in the workplace

Employers say that back pain-related problems account for over 100 million lost workdays a year. In a cutthroat economy with unemployment at a record high, this is especially disconcerting news. Employees cannot afford to risk losing their jobs to other candidates while stuck home in bed recuperating. With 80% of Americans experiencing back pain in their lifetime, back issues have serious implications on job security and can negatively affect even the most dedicated employee’s performance abilities and job attendance.

12 Nov 2009

Millennium Laboratories announces new clinical quantitative assay and drug screening tests for healthcare

Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today the company’s development and validation of a clinical quantitative assay for the new drug tapentadol (Nucynta™) by liquid chromatography/tandem mass spectrometry (LC-MS/MS).

12 Nov 2009

Investors are betting on upcoming medical study results of BioElectronics, says BioMedReports

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that investors are betting that BioElectronics' (PINKSHEETS: BIEL) upcoming medical study results will be significant.

12 Nov 2009

Pain News and Research

Latest Pain News and Research

New science of happiness doing a profound disservice

Southeast Pain Care supports American Pain Foundation

Orthopedic surgeon specializes in cutting-edge shoulder procedures from a 45-minute technique

Findings on the use of Traumeel S in children with mucositis undergoing SCT presented

Root canal treatment: Pennsylvania Dental Association answers patients' questions

Laser expert develops new technique for hair removal in ethnic skin types

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

CRPS patients fare better with aggressive physiotherapy treatment, says new study

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

Abbott to acquire the global rights to PanGenetics' new therapeutic for treatment of chronic pain

Positive results from Lexicon Pharmaceuticals' LX1031 Phase 2 study for IBS

Mouth: A diagnostic indicator for general health

Bioniche Pharma acquires injectable drugs from Xanodyne Pharmaceuticals

Artificially increasing selenium status above the level required is unwarranted, study calls for further research

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Frequent heartburn is painful and impacts the quality of life: Study

A discreet option for pain relief in the workplace

Millennium Laboratories announces new clinical quantitative assay and drug screening tests for healthcare

Investors are betting on upcoming medical study results of BioElectronics, says BioMedReports

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pain News and Research

Latest Pain News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in